Petrelintide 2766385-23-1: Petrelintide is an investigational, long-acting amylin analog being studied for obesity and metabolic disease. It is designed to promote satiety, reduce food intake, and support weight management. Clinical research is evaluating its efficacy, safety, tolerability, and potential role in improving metabolic health.